BRIEF-Pfizer's pain drug Lyrica meets goal in late-stage pediatric epilepsy study
December 01, 2016 at 08:20 AM EST
* lyrica (pregabalin) phase 3 trial in pediatric epilepsy meets primary endpoint
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.